NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images

SIMPLE SUMMARY: Lung cancer and in particular non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related death. The development of new therapeutic approaches, including immunotherapy, has led to substantial improvement in survival time and quality of life. However, the clinical b...

Descripción completa

Detalles Bibliográficos
Autores principales: Liberini, Virginia, Mariniello, Annapaola, Righi, Luisella, Capozza, Martina, Delcuratolo, Marco Donatello, Terreno, Enzo, Farsad, Mohsen, Volante, Marco, Novello, Silvia, Deandreis, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464855/
https://www.ncbi.nlm.nih.gov/pubmed/34572771
http://dx.doi.org/10.3390/cancers13184543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464855/
https://www.ncbi.nlm.nih.gov/pubmed/34572771
http://dx.doi.org/10.3390/cancers13184543

Ejemplares similares